3-glycosyl-3-odemethylthiocolchicine
Small moleculeexperimental
Clinical trial activity
1 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Dec 1, 2016 (NCT02568826)
Timeline
2010s
- Jan 1, 2016
Earliest Phase 2 Sponsor(trial)
Indications
Studied for
Mechanism of action
- P2X7 purinoceptorINHIBITOR
P2X7 inhibitor
- P2X purinoceptor 2INHIBITOR
P2RX2 inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- 3-glycosyl-3-odemethylthiocolchicine
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02568826 | Phase 2 | Dec 1, 2016 | Catholic University of Sacred Heart, Rome, Indena S.p.A, Sintesi Research Srl |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Catholic University of Sacred Heart, Rome | Academic/Hospital | 1 | 0 | 1 | 2016 |
| Indena S.p.A | For profit | 1 | 1 | 1 | 2016 |
| Sintesi Research Srl | For profit | 1 | 0 | 1 | 2016 |
3 organizations
Page 1 / 1